Catalysts for Retevmo
19 tracked
Nov 20, 2025
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Nov 20, 2025
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Nov 20, 2025
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Nov 20, 2025
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Dec 18, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Dec 18, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Sep 27, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Sep 27, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Sep 27, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Sep 27, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Jun 12, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Jun 12, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
May 29, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Apr 10, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Apr 10, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Sep 21, 2022
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Sep 21, 2022
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Jan 28, 2021
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
May 8, 2020
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→